Ranbaxy Recalls More Batches Of Suspect Lipitor Generic In U.S.
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories ordered a recall of two more batches of more than 64,000 bottles of its generic version of Pfizer's Lipitor (atorvastatin) cholesterol drug in the U.S. after finding a pill of twice the dosage in a bottle of 10-milligram tablets.